| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

MetLife Inc. (NYSE:MET) Quarterly Earnings Preview

MetLife Inc. (NYSE:MET) is set to release its quarterly earnings on November 5, 2025, after the market closes. Analysts have estimated an earnings per share (EPS) of $2.31, with revenue projected at $18.64 billion. MetLife is a leading global provider of insurance, annuities, and employee benefit programs, competing with companies like Prudential Financial and Aflac.

Analysts are optimistic about MetLife's performance, with the Zacks Consensus Estimate predicting an EPS of $2.33, a 20.7% increase from the previous year. This growth is driven by higher premiums, increased group benefits revenues, and strong international operations. Revenue is expected to reach $18.8 billion, reflecting a 7% year-over-year growth.

Despite these positive projections, MetLife faces challenges such as rising costs and weaker results in its Retirement and Income Solutions segment. These factors may temper profit gains. However, the earnings estimate has improved over the past month, indicating positive sentiment among analysts.

MetLife's financial metrics provide insight into its valuation and performance. The company has a price-to-earnings (P/E) ratio of approximately 12.43, showing the price investors are willing to pay for each dollar of earnings. The price-to-sales ratio is about 0.72, suggesting investors pay 72 cents for every dollar of sales.

The enterprise value to sales ratio is around 0.69, reflecting MetLife's valuation compared to its sales. The enterprise value to operating cash flow ratio is approximately 3.21, indicating how well the company can cover its enterprise value with its operating cash flow. The earnings yield is about 8.04%, providing insight into the return on investment for shareholders.

Published on: November 5, 2025